Pain

Using a Pain Diary

A pain diary to record chronic pain patterns and triggers can be useful to improve control of pain management.

Comparing Nociceptive and Neuropathic Pain

Antidepressants in Pain Management

Pain in the Lower Right Abdomen: When to be Concerned

Chronic Pain: The 20 Most Painful Conditions

Latest Pain News and Research

Genetic research links KDF1 mutation to impaired dental epithelial organization

Dental enamel is the hardest substance in the human body, protecting teeth from wear, temperature changes, and decay. However, enamel cannot regenerate once damaged. Inherited disorders, such as amelogenesis imperfecta, disrupt enamel formation during development, leaving affected individuals with fragile, discolored, and decay-prone teeth.

30 Jun 2026

Telehealth mindfulness program reduces chronic low back pain

Low back pain affects over 600 million people and is the single leading cause of disability worldwide.

29 Jun 2026

Scientists discover 70 existing drugs that block deadly hantavirus infections

Researchers screened over 5,000 compounds and successfully pinpointed 70 existing drugs, including unexpected beta-lactam antibiotics, that effectively suppress Puumala orthohantavirus infection in human cells. This milestone drug-repurposing study provides an immediate, fast-tracked pipeline for developing the first approved treatments against life-threatening hantavirus diseases.

28 Jun 2026

Rare pelvic schwannoma removed with nerve-sparing laparoscopic surgery

Through interdepartmental collaboration, a young woman's quality of life and ability to walk were restored following the laparoscopic removal of a rare, benign tumor of neurological origin in the lesser pelvis, known as a schwannoma (also called a neurinoma).

26 Jun 2026

New discovery sheds light on how the human body controls Salmonella infections

Salmonella, an infection that causes diarrhea, fever, and abdominal pain, is the most common form of bacterial food poisoning in the U.S., sickening more than a million people each year.

26 Jun 2026

Varicella-zoster virus inflicts lasting damage to nerves and the brain, study reveals

For millions worldwide, herpes zoster pain does not end when the rash fades. Postherpetic neuralgia can last for years or even a lifetime, devastating quality of life.

26 Jun 2026

Semaglutide approval drove a surge in GLP-1 poison center exposures

Following semaglutide's approval, poison center reports of GLP-1 RA exposures doubled, revealing critical trends in patient safety and healthcare utilization.

26 Jun 2026

Dogs could transform the future of autism drug development

For thirty years the search for autism medicines has hit the same wall, and a new peer-reviewed Perspective in Genomic Psychiatry suggests that the way around it has been sleeping at our feet the entire time.

25 Jun 2026

Good oral health could improve athletic performance

Millions of fans around the world will be glued to screens in the coming weeks to watch remarkable displays of speed, precision and endurance in the world's most important football competition.

25 Jun 2026

Musculoskeletal pain in children is often underestimated and misunderstood

Three out of every ten Brazilian children and adolescents complain of musculoskeletal pain (affecting bones, ligaments, and muscles).

25 Jun 2026

Study shows unequal access to specialized chronic pain rehabilitation

Patients with chronic pain do not have access to specialized rehabilitation on equal terms. Education, age, sex, and region of birth appear to play a role, particularly in combination, according to a Sweden-based study from the University of Gothenburg.

25 Jun 2026

Immune cells drive abnormal joint tissue growth in rheumatoid arthritis

Researchers at Hospital for Special Surgery (HSS) have identified a specialized population of immune cells that play a central role in driving abnormal tissue growth in rheumatoid arthritis (RA), offering new insight into disease progression and potential treatment strategies.

24 Jun 2026

Socioeconomic factors alter patient experiences during lung cancer screening

New research among lung cancer screening participants has found that low-dose chest computed tomography (CT) screening is generally well tolerated both physically and emotionally, but experiences vary across socioeconomic groups.

24 Jun 2026

Study compares menopause symptom burden across different age groups

There has been a lot of discussion about how the age at menopause can affect menopause symptoms. A new study compared the prevalence and severity of menopause symptoms in women experiencing menopause around the average age of 51 years and those with premature ovarian insufficiency, showing similar symptom burden in the psychological and urogenital domains.

24 Jun 2026

Natural microbial compound helps protect the gut from chronic inflammation

University of Louisville researchers have discovered how a naturally occurring microbial compound may help protect the gut and support future treatment strategies for inflammatory bowel disease (IBD).

24 Jun 2026

Electroacupuncture relieves neuropathic pain and anxiety by activating specific brain circuit

Neuropathic pain affects nearly 10% of the global population, and up to 60% of those individuals also struggle with anxiety or other mood disorders.

24 Jun 2026

New study identifies brain circuits behind spontaneous and voluntary laughter

Laughter is a universal social signal that connects us with others, but the brain regions underlying laughter are not well understood, in part because it's hard to elicit genuine laughter in the lab.

23 Jun 2026

Revolutionary protective shoe concept provides increased comfort and minimizes strain

A revolutionary protective shoe concept adapts to the needs of users in a new way and provides increased comfort and minimizes strain.

23 Jun 2026

The menstrual cycle changes heart-rate variability but not strength

Menstrual cycle phases influence heart autonomic regulation, showing HRV variations, yet muscle performance and mood states remain largely unchanged.

23 Jun 2026

Insilico and SK Biopharmaceuticals partner to develop AI-driven neuroimmune therapies

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and SK Biopharmaceuticals, a Korean-based company leads the way in biotech innovation with groundbreaking drug research, development, and commercialization worldwide, announced a research and development collaboration at the BIO 2026 International Convention to discover AI-enabled innovative drug candidates in the neuroimmune area of the central nervous system.

22 Jun 2026